Talking to Your Doctor About Your Diagnosis

The FDA has approved Stoboclo and Osenvelt to address skeletal issues faced by patients with cancer.

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

Fractionated reirradiation is safe and feasible, suggesting higher reirradiation dose may be feasible in patients with recurrent high-grade glioma.

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews

Researchers have found Brukinsa to be a potentially safer alternative for patients with chronic lymphocytic leukemia.

Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.